Full-Time

Manager – Itrms Iam Ops

Posted on 6/12/2025

Deadline 7/31/25
Merck

Merck

10,001+ employees

Develops medicines and vaccines for health issues

No salary listed

Mid, Senior

Hyderabad, Telangana, India

Category
Generalist Operations
Quality Control & Compliance
Operations & Logistics
Required Skills
PowerShell
Java
Linux/Unix
Requirements
  • MSc Degree or BSc Degree or equivalent with relevant experience in Computer Science, Computer Science Engineering, or equivalent experience.
  • 3-7 years of experience supporting large scale enterprise Identity and Access Management environments and related services.
  • Ability to provide support for Real-time events providing moderated services.
  • Ability to acquire new skills in a diverse environment.
  • Fluent in English, in both verbal and written communication.
Responsibilities
  • Day to Day operation supporting multiple Identity and Access Management services, Ping Access, Deli Nea Secret Server, Symantec VIP for multi factor authentication, MS Authenticator, SailPoint Identity Now, Quest Password Manager and Hitachi Password Manager.
  • Perform installation of security patches, version upgrade, support bug fixes, performance tuning and reporting of all the Identity and Access Management products.
  • Co-ordinate, provide guidance and support services during the critical service outages.
  • Gather business and technical requirements to setup Single Sign-On (SSO) with third party vendor applications.
  • Co-ordinate with multiple application and infrastructure teams to identify privileged accounts and onboard to Dele Nia Secret Server to mitigate the security risks.
  • Perform SailPoint Identity Now configuration and support of the access certifications such as Identity Certifications, perform the periodic access reviews for applications to comply with audit requirements.
  • Perform product migration analysis and support for Identity and Access Management Services.
  • Evaluate the services using different monitoring tools, conduct meetings with the clients to present the existing security gaps and enhancements to avoid security breaches.
  • Establish periodic vulnerability scans of the Identity and Access Management services to mitigate any security vulnerabilities.
  • Conduct Disaster Recovery (DR) exercises to ensure there is no/very minimal impact to the Identity and access management services during any disaster in any of the data canters.
  • Utilize Java/Linux script/PowerShell script to automate security features not supported by the product by extending the product APIs (Application Program Interface).
  • Conduct meetings with multiple security teams, gather requirements and specifications from clients. Validate, check feasibility and plan implementation.
  • Drive improvement, quality and value.
  • Least privileged access concepts necessary.
  • Experience with Microsoft Windows Server infrastructure.
  • Experience with RedHat Linux infrastructure.
  • Advanced knowledge of large networks including F5 load balancers concepts.

Merck & Co., Inc. is a global healthcare company that develops medicines and vaccines to address significant health challenges such as cardiovascular disease, diabetes, and cancer. The company conducts extensive research and development to create new treatments, focusing on the pharmaceutical and biotechnology sectors. Merck generates revenue through the sale of prescription medicines, vaccines, and animal health products. A key aspect of Merck's approach is its commitment to patient assistance programs, which provide free medicines and vaccines to eligible patients, as well as professional resources through platforms like Merck Connect and Merck Manuals. This focus on both innovation in healthcare and support for patients sets Merck apart from its competitors, with the goal of improving health outcomes globally.

Company Size

10,001+

Company Stage

IPO

Headquarters

Kenilworth, Illinois

Founded

1891

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven drug discovery enhances Merck's R&D efficiency and innovation.
  • Merck's $1 billion investment in a vaccine site boosts U.S. manufacturing capabilities.
  • The rise of personalized medicine aligns with Merck's focus on targeted therapies.

What critics are saying

  • Merck's mumps vaccine efficacy claims face legal challenges, risking reputation damage.
  • Susonity cosmetics brand launch may divert focus from core pharmaceutical business.
  • U.S. manufacturing expansion faces risks from potential trade policy changes.

What makes Merck unique

  • Merck invests heavily in R&D, focusing on innovative medicines and vaccines.
  • The company offers patient assistance programs, providing free medicines to qualified patients.
  • Merck's global presence allows it to serve diverse clientele worldwide.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Holidays

Paid Vacation

Paid Sick Leave

Hybrid Work Options

Flexible Work Hours

Company News

News Channel Nebraska
Jun 4th, 2025
AI Networking Summit Dallas 2025 Breaks Records and Sets the Stage for the Future of AI-Powered Enterprises

Merck's Sean Finnerty was awarded a Community Appreciation Award for sharing how Merck is using AI to speed up and save software development costs.

Personal Care Magazine
May 30th, 2025
Merck reveals launch of Susonity brand for cosmetics

Merck reveals launch of Susonity brand for cosmetics.

MyCentralJersey
May 29th, 2025
NJ drug companies will spend billions to expand in the U.S. Here's what's driving them

Rahway-based drugmaker Merck last month announced plans to spend $1 billion on a vaccine manufacturing site in North Carolina, plus $8 billion on other upgrades by 2028.

Natural News
May 22nd, 2025
Merck's mumps fraud: A 50-year cover-up exposed as vaccine efficacy claims crumble

Merck's mumps vaccine, part of the MMR shots, is confirmed to be far less effective than claimed, with courts acknowledging intentional fraud to maintain monopoly and avoid admitting failure.

Merck
May 22nd, 2025
Merck to Participate in the Bernstein 41st Annual Strategic Decisions Conference

Merck to participate in the Bernstein 41st Annual Strategic Decisions Conference.